These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 3002979)

  • 1. Renal and systemic effects of enalapril in chronic one-kidney hypertension.
    Woods RL; Anderson WP; Korner PI
    Hypertension; 1986 Feb; 8(2):109-16. PubMed ID: 3002979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of angiotensin II in the development of hypertension and in the maintenance of glomerular filtration rate during 48 hours of renal artery stenosis in conscious dogs.
    Selig SE; Anderson WP; Korner PI; Casley DJ
    J Hypertens; 1983 Aug; 1(2):153-8. PubMed ID: 6099382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of angiotensin II in the hypertension induced by renal artery stenosis.
    Anderson WP; Selig SE; Korner PI
    Clin Exp Hypertens A; 1984; 6(1-2):299-314. PubMed ID: 6697556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril in treatment of hypertension with renal artery stenosis. Changes in blood pressure, renin, angiotensin I and II, renal function, and body composition.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    Am J Med; 1984 Aug; 77(2A):52-60. PubMed ID: 6089557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute renal haemodynamic and renin-angiotensin system responses to graded renal artery stenosis in the dog.
    Anderson WP; Johnston CI; Korner PI
    J Physiol; 1979 Feb; 287():231-45. PubMed ID: 219182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of stenosis resistance to the rise in total peripheral resistance during experimental renal hypertension in conscious dogs.
    Anderson WP; Korner PI; Angus JA; Johnston CI
    Clin Sci (Lond); 1981 Dec; 61(6):663-70. PubMed ID: 7028365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic hemodynamic responses to chronic angiotensin II infusion into the renal artery of dogs.
    Fitzgerald SM; Stevenson KM; Evans RG; Anderson WP
    Am J Physiol; 1997 Dec; 273(6):R1980-9. PubMed ID: 9435652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative contribution of vasopressin and angiotensin II to the altered renal microcirculatory dynamics in two-kidney Goldblatt hypertension.
    Ichikawa I; Ferrone RA; Duchin KL; Manning M; Dzau VJ; Brenner BM
    Circ Res; 1983 Nov; 53(5):592-602. PubMed ID: 6194914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal actions of angiotensin II in renovascular hypertension.
    Anderson WP; Woods RL; Denton KM; Alcorn D
    Can J Physiol Pharmacol; 1987 Aug; 65(8):1559-65. PubMed ID: 3690389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril in hypertension with renal artery stenosis: long-term follow-up and effects on renal function.
    Tillman DM; Malatino LS; Cumming AM; Hodsman GP; Leckie BJ; Lever AF; Morton JJ; Webb DJ; Robertson JI
    J Hypertens Suppl; 1984 Dec; 2(2):S93-100. PubMed ID: 6100883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
    Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
    Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total peripheral resistance responsiveness during the development of secondary renal hypertension in dogs.
    Anderson WP; Shweta A; Evans RG; Edgley AJ; Gao Y
    J Hypertens; 2007 Mar; 25(3):649-62. PubMed ID: 17278982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the converting enzyme inhibitor enalapril in renovascular hypertension. Effect on blood pressure, renal function, and the renin-angiotensin-aldosterone system.
    Reams GP; Bauer JH; Gaddy P
    Hypertension; 1986 Apr; 8(4):290-7. PubMed ID: 3007351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced slow pressor effect of angiotensin II in two-kidney, one clip rats.
    Melaragno MG; Fink GD
    Hypertension; 1995 Feb; 25(2):288-93. PubMed ID: 7843781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of angiotensin II in renal wrap hypertension.
    Denton KM; Anderson WP
    Hypertension; 1985; 7(6 Pt 1):893-8. PubMed ID: 3000937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
    Bagby SP; Fuchs EF
    Hypertension; 1989 Feb; 13(2):91-101. PubMed ID: 2536643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II is a necessary component for the development of hypertension in the two kidney, one clip rat.
    DeForrest JM; Knappenberger RC; Antonaccio MJ; Ferrone RA; Creekmore JS
    Am J Cardiol; 1982 Apr; 49(6):1515-7. PubMed ID: 6280481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.